The Future Gold
Standard in
Newrotex develops innovative silk-based medical
solutions for the nervous system.
Newrotex develops innovative silk-based medical
solutions for the nervous system.
The answer to “Can you repair nerves?” shouldn’t come with caveats. This is why Newrotex is set to disrupt existing approaches to surgical nerve repair. We’re on track to provide an alternative to autografts, the current gold standard in treatment for nerve injuries. A gold standard that requires sacrificing a healthy nerve from another part of the body. With our patented silk-based technology, we’ll deliver an off-the-shelf solution for surgical repair of the nerve. Without the need for long, complicated operations or using expensive donor tissues, Newrotex makes immediate treatment possible for patients who have suffered nerve injuries due to trauma, medical conditions, or surgical treatments.
Annual operations for nerve injuries
Newrotex silk-based nerve products address the shortcomings of the solutions currently available.
Most of the world’s 1.5 million annual operations for nerve injuries are treated with autografts requiring a second injury and long surgery times, along with risking donor site morbidity and infection.
All of the major current solutions – autografts, allografts, and hollow tube conduits – are limited when repairing large gaps in nerves. Read Current Approaches for more about these and other shortcomings with current solutions for peripheral nerve repair.
Over the past few decades, the potential biomedical applications of silk have been gaining interest at an exponential rate.
The versatility created by silk’s chemical structure allows for the production of fibres, gels, scaffolds, films, membranes, and powders. Silk has shown to have excellent cell affinity, and being biocompatible, with the ability to tailor biodegradation, silk is an ideal candidate for biomedical applications.
In terms of nerve repair, luminal silk fibres inside a vein or conduit guide regenerating axons, while the bioabsorbable, permeable tube allows nutrients to support nerve regeneration. Furthermore, silk products can be stored at room temperature, thereby removing the need for expensive cold storage and transportation.
Our first product is a 10cm implant made from bundles of luminal spider silk fibres that can be implanted into a vein or inserted into hollow conduits to support nerve re-growth. Pre-clinical studies have show that SilkAxons® support superior axonal regeneration.
Our second product is an off-the-shelf silk-based peripheral nerve conduit pre-filled with enhancing luminal silk fibres, negating the need to use a vein.
The fibres have proven nerve-regenerating properties and clinical trials show them to be comparable or superior to autografts. And with a porous tubular biocompatible sheath designed to encourage vascularisation, we provide a new and better approach to treating patients with peripheral nerve injuries.
Newrotex launched a first-in-human clinical trial in Q3 2025 using SilkAxons® to bridge large nerve gaps of up to 10cm (significantly more than current FDA approved devices). This study will generate foundational data for Newrotex’s global clinical strategy. Our goal is to commence a large study this year culminating in an application for market approval in the USA and UK. We are also developing collaborations in which our silk platform technology may lead to further improvements in patient care, such as Schwann cell delivery and spinal cord injury repair.
Aindham Vedham (The Fifth Veda) is a 2024 ZEE5 original mystery thriller that marks the return of legendary director Naga—known for the cult classic Marmadesam—to the supernatural genre. The eight-episode series blends ancient Indian mythology and spirituality with modern concepts like artificial intelligence and planetary science. Watch the official trailer for this mythological thriller:
The character dynamics in Season 1 serve as the emotional anchor for the complex plot. aindham vedham season 1
Over 10,000 applicants took a written test at 12 centers across Tamil Nadu, Karnataka, and Andhra Pradesh. Selected 108 contestants (an auspicious number) were brought to Chennai. They were further filtered through an oral Vedic chanting round, resulting in 27 finalists for the main show. Aindham Vedham (The Fifth Veda) is a 2024
This is the most common query related to "Aindham Vedham Season 1." As of the latest updates, ZEE5 has not officially announced a second season. The first season concluded with a definitive end to the immediate murder case but introduced a larger cosmic threat. Given the positive reviews and cult following, fans remain hopeful, but no production updates have been confirmed. Senthil (The Reluctant Hero): Unlike typical action heroes,
In 2022, Zee Tamil launched Aindham Vedham, hosted by the charismatic actor and television personality Ma Ka Pa Anand. Unlike conventional quiz shows (e.g., Kaun Banega Crorepati), Aindham Vedham adopted a tournament structure: 16 contestants—including software engineers, civil service aspirants, doctors, and lawyers—competed in knockout rounds, culminating in a grand finale. The title invokes the four canonical Vedas (Rig, Yajur, Sama, Atharvana) and posits competitive knowledge as a “fifth” scripture, thereby sacralizing secular intellect.
The finale (Episode 26) was a two-hour live event from the Sri Ekambaranathar Temple in Kanchipuram. The top three finalists—a 19-year-old engineering student from Coimbatore, a 67-year-old retired Sanskrit teacher from Tirunelveli, and a homemaker from Chennai—faced 15 questions from the Gurus directly.